Skip to content

Posts Tagged Lynne Maquat

Posts Loop

Lynne Maquat, surrounded by colleagues and balloons, smiles and looks to the side during a press conference.
University News
October 9, 2024 | 02:50 pm

Lynne Maquat wins Albany Prize, Janssen Award

The recent honors recognize Maquat’s foundational research on the RNA mechanisms that contribute to a wide range of diseases.

topics: awards, Department of Biochemistry and Biophysics, Lynne Maquat, School of Medicine and Dentistry,
Two RNA research scientists in a lab analyzing the results of an experiment on a computer monitor.
Science & Technology
May 10, 2024 | 11:02 am

Rochester and Albany launch new Center of Excellence in RNA research

The joint venture between the University of Rochester and University at Albany will drive economic development through research and training.

topics: Center for RNA Biology, Department of Biology, Lynne Maquat, Medical Center, Office of Government and Community Relations, research funding, School of Arts and Sciences, School of Medicine and Dentistry,
Illustration of coronavirus protein binding to receptor on human cell.
Science & Technology
December 14, 2020 | 02:30 pm

COVID-19 vaccine: What’s RNA research got to do with it?

RNA research at the University of Rochester provides an important foundation for developing antiviral drugs, vaccines, and other therapeutics to disrupt the global spread of coronavirus.

topics: Center for RNA Biology, COVID-19, Department of Biochemistry and Biophysics, Department of Biology, Douglas Anderson, Dragony Fu, featured-post, Lynne Maquat, Medical Center, School of Arts and Sciences,
220 nobel prize recipient Harvey Alter
Science & Technology
October 9, 2020 | 09:44 am

Harvey Alter’s Nobel Prize honors a half-century quest

Nobel laureate Harvey Alter’s work as an NIH hematologist led to profound improvements in blood transfusion safety and starkly reduced transmission of a potentially deadly virus.

topics: awards, Harvey Alter, Joel Blumberg, Lynne Maquat, Nobel Prize, School of Medicine and Dentistry,
doctor's hands injecting syringe into patient
Science & Technology
March 26, 2015 | 05:40 pm

Blocking cellular quality control mechanism gives cancer chemotherapy a boost

A University team found a way to make chemotherapy more effective by exposing cancer cells to a molecule that inhibits NMD (nonsense-mediated mRNA decay) prior to treatment with doxorubicin, a drug used to treat leukemia, breast, bone, lung and other cancers.

topics: cancer, Center for RNA Biology, Lynne Maquat, Medical Center, research finding,